Breast, endocrine, head and neck Flashcards
(211 cards)
Reasons for parathyroidectomy in asymptomatic hyperparathyroidism
Age <50
T or Z score 2.5 on DEXA
eGFR <60
Vertebral fractures on radiological evaluation
Renal stones on radiological evaluation
Serum calcium >0.25mmol/L over reference range
5 Things to look for on a mammogram
Mass
Calcifications
Architectural distortion
Spiculation
Skin changes
Benign breast disease can be best grouped into which three categories
- Give an example of each
Non proliferative
- Cysts
- Papillary apocrine change
- Mild hyperplasia of the usual type
Proliferative without atypia
- Usual ductal hyperplasia
- Intraductal papillomas
- Single or diffuse papillomatosis
- Sclerosing adenosis
- Radial scars (complex sclerosing lesions)
- Fibroadenomas
Proliferative with atypia
- Atypical ductal hyperplasia
- Atypical lobular hyperplasia
- Lobular carcinoma in situ
- Flat epithelial atypia
Benign proliferative breast lesions with atypia
Atypical hyperplasia
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
Lobular carcinoma in situ (LCIS)
Flat epithelial atypia (FEA)
- No increase in cancer risk
Hypertrophy
Enlargement of individual cells
Hyperplasia
Increase in number of cells
MEN1
Autosomal dominant
Rare
Clinically defined as either:
- The occurence of 2 or more MEN1 tumour types
- 1 MEN1 tumour type with a family history of clinical MEN1
Defects in the MEN1 gene
- Encodes menin
Three main effects
- Primary hyperparathyroidism
- Pituitary adenomas
- Pancreatic NETs
- Gastrinoma (ZES) most common
- Both functional and non functional
Other associations
- Thymic carcinoid (non functional)
- Collaginomas
- Adrenocortical nodular hyperplasia
- Lipomas
- Angiofibromas
MEN2
Rare
Autosomal dominant
Defects in RET proto-oncogene on chromosome 10
Subclassified in MEN2A and MEN2B
Both develop:
- Medullary thyroid cancer
- Phaeochromocytoma
MEN2A only
- Hyperparathyroidism
What percentage of breast cancers are hormone receptor positive
75%
As a general rule what is the benefit to survival with 5 years of Tamoxifen
Reduces the risk of death by around 1/3 (RR 0.7) during treatment, and
- this effect continues for years 5-9
What is the role for Ovarian suppression in breast cancer
Adjuvant therapy
Improves survival in premenopausal women who also require chemotherapy
- especially in early age
Goserelin is the most studied agent
- Side effects are significant
- Hot flushes
- Hypertension
- MSK symptoms
- Depression
What are the 2 main side effects of Tamoxifen
VTE
Uterine carcinoma
Monitoring bone loss in aromatase inhibitor use
How is this treated
Dexa scan every 2 years
Treatment with bisphosphonates
What is the rate of Amenorrhoea after chemotherapy in breast cancer,
What should be offered to premenopausal women who may require chemotherapy
50%
Fertility consultation and egg banking
Goserelin may reduce this risk significantly
What improvement in recurrence of breast cancer does chemotherapy generally offer
25% annual risk reduction
- This holds true for most situations
- High risk disease simply has a greater benefit as a function of the higher recurrence rates
What do the AJCC grading guidelines classify as chest wall invasion
The chest wall includes ribs, intercostal muscles, and serratus anterior muscle, but not the pectoral muscles.
Therefore, involvement of the pectoral muscle in the absence of invasion of these chest wall structures or skin does not constitute chest wall invasion
such cancers are categorized on the basis of tumor size
Usual lymphatic drainage of the breast.
What sites are considered regional vs metastatic disease in breast cancer
The breast lymphatics drain by way of three major routes:
- axillary
- interpectoral
- internal mammary.
Intramammary lymph nodes reside within breast tissue and are designated as axillary lymph nodes for staging purposes.
Supraclavicular lymph nodes are categorized as regional lymph nodes for staging purposes.
Metastases to any other lymph nodes, including cervical or contralateral internal mammary or contralateral axillary lymph nodes, are classified as distant metastases
Axillary (ipsilateral): interpectoral (Rotter’s) nodes and lymph nodes along the axillary vein and its tributaries may be divided into the following levels:
Level I (low-axilla):
- lymph nodes lateral to the lateral border of pectoralis minor muscle.
Level II (mid-axilla):
- lymph nodes between the medial and lateral borders of the pectoralis minor muscle
- interpectoral (Rotter’s) lymph nodes.
Level III (apical axilla):
- lymph nodes medial to the medial margin of the pectoralis minor muscle and inferior to the clavicle.
- also known as apical or infraclavicular nodes.
- Metastases to these nodes portend a worse prognosis.
- the infraclavicular designation should be used to differentiate these nodes from the remaining (Level I, II) axillary nodes.
- Level III infraclavicular nodes should be separately identified by the surgeon for microscopic evaluation.
Where are the internal mammary nodes
Intercostal spaces along the edge of the sternum in the endo- thoracic fascia.
How are supraclavicular lymph nodes defined anatomically.
Lymph nodes in the supraclavicular fossa
- triangle defined by the omohyoid muscle and tendon (lateral and superior border),
- internal jugular vein (medial border)
- clavicle and subclavian vein (lower border).
Adjacent lymph nodes outside of this triangle are considered to be lower cervical nodes (M1).
To which organs does breast cancer metastasize
The four most common sites of involvement are
- bone
- lung
- brain
- liver
breast cancers also are capable of metastasizing to many other sites
Breast cancer staging:
T1

Breast cancer staging:
T2 and T3 disease
T2
- 2-5cm
T3
- >5cm (not invading chest wall or skin)
Breast cancer staging:
T4a and T4b disease










